Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial
瑞波替尼治疗NTRK融合阳性晚期实体瘤:一项1/2期试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-04079-7
Besse, Benjamin; Lin, Jessica J; Bazhenova, Lyudmila; Goto, Koichi; de Langen, Adrianus Johannes; Kim, Dong-Wan; Wolf, Jürgen; Springfeld, Christoph; Popat, Sanjay; Lim, Darren W T; Nagasaka, Misako; Hong, Jung Yong; Baik, Christina S; Hervieu, Alice; Moreno, Victor; Yang, Nong; Kollengode, Kanthi; Yang, Haisu; Xu, Yuanfang; Calvet, Christophe Y; Yuan, Yong; Hammell, Amy B; Drilon, Alexander; Solomon, Benjamin J